Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opportunities for Treg cell therapy for the treatment of human disease. | Front Immunol | 2023 | 37153574 | PubTator, text mining | PubMed |
| Azelaic Acid Regulates the Renin-Angiotensin System and Improves Colitis Based on Network Pharmacology and Experimentation. | ACS Omega | 2023 | 37151561 | PubTator, text mining | PubMed |
| Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study. | Adv Ther | 2023 | 37140705 | PubTator, text mining | PubMed |
| Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. | Ann Rheum Dis | 2023 | 37130727 | PubTator, text mining | PubMed |
| The role of group 3 innate lymphoid cell in intestinal disease. | Front Immunol | 2023 | 37122757 | PubTator, text mining | PubMed |
| Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. | Pharmaceuticals (Basel) | 2023 | 37111294 | PubTator, text mining | PubMed |
| The Fungal and Bacterial Interface in the Respiratory Mycobiome with a Focus on Aspergillus spp. | Life (Basel) | 2023 | 37109545 | PubTator, text mining | PubMed |
| Intestinal Lymphatic Dysfunction in Kidney Disease. | Circ Res | 2023 | 37104557 | PubTator, text mining | PubMed |
| CHST2-mediated sulfation of MECA79 antigens is critical for breast cancer cell migration and metastasis. | Cell Death Dis | 2023 | 37095090 | PubTator, text mining | PubMed |
| FRC transplantation restores lymph node conduit defects in laminin α4-deficient mice. | JCI Insight | 2023 | 37092548 | PubTator, text mining | PubMed |
| Increased Motility and Suppression of Ex Vivo-Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis. | Cell Mol Gastroenterol Hepatol | 2023 | 37085136 | PubTator, text mining | PubMed |
| Intestinal Peyer's Patches: Structure, Function, and In Vitro Modeling. | Tissue Eng Regen Med | 2023 | 37079198 | PubTator, text mining | PubMed |
| Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. | PeerJ | 2023 | 37065697 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case report. | SAGE Open Med Case Rep | 2023 | 37063436 | PubTator, text mining | PubMed |
| Role of CD34 in inflammatory bowel disease. | Front Physiol | 2023 | 37051017 | PubTator, text mining | PubMed |
| Uncovering the Underworld of Axial Spondyloarthritis. | Int J Mol Sci | 2023 | 37047435 | PubTator, text mining | PubMed |
| The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. | Int J Mol Sci | 2023 | 37047140 | PubTator, text mining | PubMed |
| Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing. | Clin Transl Med | 2023 | 37029786 | PubTator, text mining | PubMed |
| Cellular heterogeneity and stem cells of vascular endothelial cells in blood vessel formation and homeostasis: Insights from single-cell RNA sequencing. | Front Cell Dev Biol | 2023 | 37025170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=11